Fundz
Back to Investors

Track Bristol Myers Squibb's Investment Activity

Get real-time alerts when Bristol Myers Squibb makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $59/mo
B

Bristol Myers Squibb

Other
Total Deals
14
Recent (90d)
0
Total Capital
$1.5B
Co-Investors
108
G

GlycoEra AG

Biotechnology
series b
$130.0M

May 27, 2025

N

Nuvig Therapeutics

BiotechnologyMenlo Park, United States
series b
$161.0M

Dec 5, 2024

A

Aktis Oncology

BiotechnologyCambridge, United States
series b
$175.0M

Sep 30, 2024

A

Autobahn Therapeutics

BiotechnologySan Diego, United States
series c
$100.0M

Jul 24, 2024

N

NeoPhore Ltd

Biotechnology ResearchLondon, United Kingdom
series b
-

May 22, 2024

9+ more investments

View all 14 deals by Bristol Myers Squibb

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.